Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke
Status:
Recruiting
Trial end date:
2023-07-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, doble blind, placebo controlled clinical trial to asses de safety and
efficacy of intravenous administration of alogenic adipose tissue-derived mesenchymal stem
cells in the first four days from acute ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz